← Open Payments lookup

NICOLE CASELLI: Open Payments

NPI 1245609171 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,586 in 14 payments from 10 companies in 2025. Trend: 2023 $811 · 2024 $1,124 · 2025 $1,586

Food & beverage: $1,586
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$373
Gilead Sciences, Inc.2$253
Novo Nordisk Inc2$242
Xeris Pharmaceuticals, Inc.1$135
Verona Pharma, Inc.1$125
Amgen Inc.1$125
Phathom Pharmaceuticals, Inc.1$123
Dexcom, Inc.1$95
Axsome Therapeutics, Inc.1$59
Hologic Sales and Service, LLC1$55

Products named: FASENRA, GVOKE HYPOPEN, Ohtuvayre, Epclusa, AIRSUPRA, KRYSTEXXA, VOQUEZNA, Ozempic.

Industry payments across DE — which companies pay providers there.